ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Society guideline links: Management of diffuse large B cell lymphoma

Society guideline links: Management of diffuse large B cell lymphoma

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

International

International Lymphoma Radiation Oncology Group (ILROG): An overview of guidelines for involved site radiation therapy in adult lymphomas (2020)

Society for Immunotherapy of Cancer (SITC): Clinical practice guideline on immunotherapy for the treatment of lymphoma (2020)

American Society for Blood and Marrow Transplantation (ASBMT), Center for International Blood and Marrow Transplant Research (CIBMTR), and European Society for Blood and Marrow Transplantation (EBMT): A consensus project on maintenance therapies for Hodgkin and non-Hodgkin lymphomas after autologous transplantation (2019)

ILROG: Guidelines for the optimal use of imaging in radiation therapy for lymphoma (2019)

ILROG: Guidelines for proton therapy for adults with mediastinal lymphomas (2018)

ILROG: Guidelines on the role of radiation therapy in patients with relapsed/refractory diffuse large B-cell lymphoma (2018)

ILROG: Field and dose guidelines for modern radiation therapy for extranodal lymphomas (2015)

ILROG: Field and dose guidelines for modern radiation therapy for primary cutaneous lymphomas (2015)

International Society of Geriatric Oncology (SIOG): Expert position commentary for the approach to therapy of diffuse large B-cell lymphoma in the elderly (2015)

SIOG: Expert position paper on diffuse large B-cell lymphoma in the elderly – Impact of prognosis, comorbidities, geriatric assessment, and supportive care on clinical practice (2015)

ILROG: Target definition and dose guidelines for modern radiation therapy for nodal non-Hodgkin lymphoma (2014)

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma – The Lugano classification (2014)

European Organisation for Research and Treatment of Cancer (EORTC) and International Society for Cutaneous Lymphomas (ISCL): Consensus recommendations for the management of cutaneous B-cell lymphomas (2008)

Canada

Cancer Care Ontario (CCO): Follow-up care for survivors of lymphoma who have received curative-intent treatment (2016)

CCO: Rituximab in lymphoma and chronic lymphocytic leukemia – A clinical practice guideline (2015)

CCO: The clinical utility of positron emission tomography in the diagnosis, staging, and clinical management of patients with lymphoma – Recommendation report (2015)

United States

American Society for Blood and Marrow Transplantation (ASBMT), Center for International Blood and Marrow Transplant Research (CIBMTR), and European Society for Blood and Marrow Transplantation (EBMT): A consensus project on maintenance therapies for Hodgkin and non-Hodgkin lymphomas after autologous transplantation (2019)

Europe

American Society for Blood and Marrow Transplantation (ASBMT), Center for International Blood and Marrow Transplant Research (CIBMTR), and European Society for Blood and Marrow Transplantation (EBMT): A consensus project on maintenance therapies for Hodgkin and non-Hodgkin lymphomas after autologous transplantation (2019)

European Society for Medical Oncology (ESMO): Consensus conference on malignant lymphoma – Management of 'ultra-high-risk' patients (2018)

ESMO: Primary cutaneous lymphomas – Clinical practice guidelines for diagnosis, treatment and follow-up (2018)

ESMO: Consensus conference on malignant lymphoma – General perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma (2017)

ESMO: Consensus conference on malignant lymphoma – General perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia (2016)

ESMO: Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma – Clinical practice guidelines for diagnosis, treatment and follow-up (2016)

ESMO: Diffuse large B-cell lymphoma (DLBCL) – Clinical practice guidelines for diagnosis, treatment and follow-up (2015)

European Organisation for Research and Treatment of Cancer (EORTC) and International Society for Cutaneous Lymphomas (ISCL): Consensus recommendations for the management of cutaneous B-cell lymphomas (2008)

United Kingdom

British Society for Haematology (BSH): A good practice paper for the prevention of central nervous system relapse in diffuse large B-cell lymphoma (2020)

British Association of Dermatologists (BAD) and UK Cutaneous Lymphoma Group (UKCLG): Guidelines for the management of primary cutaneous lymphomas, 2018 (published 2019)

BSH: Guidelines for the diagnosis and management of primary central nervous system diffuse large B-cell lymphoma (2019)

British Committee for Standards in Haematology (BCSH): Guidelines for the management of diffuse large B-cell lymphoma (2016)

National Institute for Health and Care Excellence (NICE): Guideline on non-Hodgkin's lymphoma – Diagnosis and management (2016)

India

Indian Council of Medical Research (ICMR): Consensus document for management of pediatric lymphomas and solid tumors (2017)

ICMR: Consensus document for management of non Hodgkin's lymphoma (high grade) (2016)

Australia–New Zealand

Choosing Wisely Australia: Limit surveillance computed tomography (CT) scans in asymptomatic patients with confirmed complete remission following curative intent treatment for aggressive lymphoma – except for patients on a clinical trial (2015)

Japan

[In Japanese] Japanese Dermatological Association (JDA) and Japanese Skin Cancer Society (JSCS): Cutaneous malignant tumor guideline – Cutaneous lymphoma clinical practice guidelines, 3rd edition (2020)

[In Japanese] Japanese Society of Pediatric Hematology/Oncology (JSPHO): Clinical guidelines for childhood leukemia/lymphoma, 3rd edition (2016)

[In English] JDA and JSCS: Guidelines for the management of cutaneous lymphomas, 2011 (published 2013)

Topic 120191 Version 18.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟